These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Cytostatic therapy of inoperable carcinomas]. Baumgartner G Wien Med Wochenschr; 1976 Jan; 126(5):59-61. PubMed ID: 986106 [No Abstract] [Full Text] [Related]
5. [Remission maintenance with cytostatic long-term therapy in metastatic breast cancer]. Beaufort F Onkologie; 1982 Aug; 5 Suppl():52-4. PubMed ID: 6813783 [TBL] [Abstract][Full Text] [Related]
6. Cyclical combination chemotherapy in advanced breast cancer. Edelstyn GA; Marcrae KD Ann R Coll Surg Engl; 1974 Jun; 54(6):275-6. PubMed ID: 4833779 [No Abstract] [Full Text] [Related]
7. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast. Lee JM; Abeloff MD; Lenhard RE; Baker RR Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006 [No Abstract] [Full Text] [Related]
8. Combination chemotherapy in disseminated carcinoma of the breast. Kaufman S; Goldstein M Surg Gynecol Obstet; 1973 Jul; 137(1):83-6. PubMed ID: 4714324 [No Abstract] [Full Text] [Related]
10. Moderately high-dosage methotrexate medication in metastatic breast cancer. Wils JA Neth J Med; 1980; 23(2):59-61. PubMed ID: 7374869 [No Abstract] [Full Text] [Related]
11. Use of anti-oestrogen Zitazonium (tamoxifen) as adjuvant to cytostatic treatment in metastatic breast cancer. Palka I; Jávor J Ther Hung; 1986; 34(4):217-23. PubMed ID: 3449976 [No Abstract] [Full Text] [Related]
12. [Progress in the chemotherapy of metastasizing breast and bronchial carcinomas]. Senn HJ Z Allgemeinmed; 1975 Jan; 51(3):104-11. PubMed ID: 1130102 [No Abstract] [Full Text] [Related]
13. The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival. Redmond C; Fisher B; Wieand HS Cancer Treat Rep; 1983 Jun; 67(6):519-26. PubMed ID: 6344993 [No Abstract] [Full Text] [Related]
14. [Control studies on the cytostatic combination therapy in metastasizing breast carcinoma]. Brunner KW; Martz G; Senn HJ; Obrecht P; Alberto P; Melchert F Internist (Berl); 1973 Dec; 14(12):643-52. PubMed ID: 4593011 [No Abstract] [Full Text] [Related]
16. [Combination chemo-endocrine therapy of metastatic and stage IV breast cancer with cyclophosphamide, adriamycin, prednisolone and tamoxifen (CAPT)--with special reference to management of brain and liver metastasis]. Nakamura Y; Kawaguchi M; Hata A; Watanabe H; Ueki Y; Oribe T; Koba F; Takamuku K Gan To Kagaku Ryoho; 1989 Feb; 16(2):243-50. PubMed ID: 2919892 [TBL] [Abstract][Full Text] [Related]
17. [Cytostatic therapy in metastasizing breast cancer]. Gynning I; Mattsson W Lakartidningen; 1978 Apr; 75(15):1512-5. PubMed ID: 651418 [No Abstract] [Full Text] [Related]
18. The effect of cytostatic therapy with cyclophosphamide alone or in combination with methotrexate on the phytohaemagglutinin lymphocyte culture and on the immunoglobulins. Lopes Cardozo E Oncology; 1970; 24(4):261-72. PubMed ID: 4193797 [No Abstract] [Full Text] [Related]
19. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast. Smalley RV; Murphy S; Huguley CM; Bartolucci AA Cancer Res; 1976 Nov; 36(11 Pt 1):3911-6. PubMed ID: 975039 [TBL] [Abstract][Full Text] [Related]
20. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy]. Mouridsen HT; Palshof T; Brahm M; Rahbek I Ugeskr Laeger; 1977 Oct; 139(44):2632-5. PubMed ID: 929742 [No Abstract] [Full Text] [Related] [Next] [New Search]